Lanford Robert E, Guerra Bernadette, Lee Helen, Averett Devron R, Pfeiffer Brad, Chavez Deborah, Notvall Lena, Bigger Catherine
Department of Virology and Immunology, Southwest National Primate Research Center, Southwest Foundation for Biomedical Research, San Antonio, Texas 78227, USA.
J Virol. 2003 Jan;77(2):1092-104. doi: 10.1128/jvi.77.2.1092-1104.2003.
The recently developed hepatitis C virus (HCV) subgenomic replicon system was utilized to evaluate the efficacy of several known antiviral agents. Cell lines that persistently maintained a genotype 1b replicon were selected. The replicon resident in each cell line had acquired adaptive mutations in the NS5A region that increased colony-forming efficiency, and some replicons had acquired NS3 mutations that alone did not enhance colony-forming efficiency but were synergistic with NS5A mutations. A replicon constructed from the infectious clone of the HCV-1 strain (genotype 1a) was not capable of inducing colony formation even after the introduction of adaptive mutations identified in the genotype 1b replicon. Alpha interferon (IFN-alpha), IFN-gamma, and ribavirin exhibited antiviral activity, while double-stranded RNA (dsRNA) and tumor necrosis factor alpha did not. Analysis of transcript levels for a series of genes stimulated by IFN (ISGs) or dsRNA following treatment with IFN-alpha, IFN-gamma, and dsRNA revealed that both IFNs increased ISG transcript levels, but that some aspect of the dsRNA response pathway was defective in Huh7 cells and replicon cell lines in comparison to primary chimpanzee and tamarin hepatocytes. The colony-forming efficiency of the replicon was reduced or eliminated following replication in the presence of ribavirin, implicating the induction of error-prone replication. The potential role of error-prone replication in the synergy observed between IFN-alpha and ribavirin in attaining sustained viral clearance is discussed. These studies reveal characteristics of Huh7 cells that may contribute to their unique capacity to support HCV RNA synthesis and demonstrate the utility of the replicon system for mechanistic studies on antiviral agents.
利用最近开发的丙型肝炎病毒(HCV)亚基因组复制子系统评估了几种已知抗病毒药物的疗效。选择了持续维持1b基因型复制子的细胞系。每个细胞系中的复制子在NS5A区域获得了适应性突变,从而提高了集落形成效率,并且一些复制子获得了NS3突变,这些突变单独不会提高集落形成效率,但与NS5A突变具有协同作用。即使引入了在1b基因型复制子中鉴定出的适应性突变,由HCV-1株(1a基因型)的感染性克隆构建的复制子仍无法诱导集落形成。α干扰素(IFN-α)、γ干扰素和利巴韦林表现出抗病毒活性,而双链RNA(dsRNA)和肿瘤坏死因子α则没有。在用IFN-α、IFN-γ和dsRNA处理后,对一系列受IFN刺激的基因(ISG)或dsRNA的转录水平进行分析,结果显示两种干扰素均增加了ISG转录水平,但与原代黑猩猩和绢毛猴肝细胞相比,Huh7细胞和复制子细胞系中dsRNA反应途径的某些方面存在缺陷。在利巴韦林存在的情况下复制后,复制子的集落形成效率降低或消除,这意味着诱导了易出错的复制。讨论了易出错复制在IFN-α和利巴韦林协同作用以实现持续病毒清除中所观察到的潜在作用。这些研究揭示了Huh7细胞的特性,这些特性可能有助于其支持HCV RNA合成的独特能力,并证明了复制子系统在抗病毒药物机制研究中的实用性。